OMERS Administration Corporation »

Karyopharm Therapeutics shares owned by OMERS Administration Corporation

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by OMERS Administration Corporation from 13F filings

Historical chart of OMERS Administration Corporation investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by OMERS Administration Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by OMERS Administration Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $108k 19k 5.57

More positions owned by OMERS Administration Corporation

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Brookfield Business Corp Cl A Sub Vtg Sh (BBUC)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Coca-Cola Company (KO)
Bank of America Corporation (BAC)
Eli Lilly & Co. (LLY)
Prologis (PLD)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Thermo Fisher Scientific (TMO)

View all positions for OMERS Administration Corporation

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
T. Rowe Price Investment Management
Goldman Sachs Group
Catalio Capital Management
Affinity Asset Advisors
Susquehanna International
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Vanguard Group
Millennium Management
Citadel Advisors

View all funds holding Karyopharm Therapeutics